Anti-XCT/ SLC7A11/ CCBR1 monoclonal antibody

Anti-XCT/ SLC7A11/ CCBR1 antibody for FACS & in-vivo assay

Target products collectionGo to SLC7A11/SLC7A11 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T11615-Ab-1/ GM-Tg-hg-T11615-Ab-2Anti-Human SLC7A11 monoclonal antibodyHuman
GM-Tg-rg-T11615-Ab-1/ GM-Tg-rg-T11615-Ab-2Anti-Rat SLC7A11 monoclonal antibodyRat
GM-Tg-mg-T11615-Ab-1/ GM-Tg-mg-T11615-Ab-2Anti-Mouse SLC7A11 monoclonal antibodyMouse
GM-Tg-cynog-T11615-Ab-1/ GM-Tg-cynog-T11615-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC7A11 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T11615-Ab-1/ GM-Tg-felg-T11615-Ab-2Anti-Feline SLC7A11 monoclonal antibodyFeline
GM-Tg-cang-T11615-Ab-1/ GM-Tg-cang-T11615-Ab-2Anti-Canine SLC7A11 monoclonal antibodyCanine
GM-Tg-bovg-T11615-Ab-1/ GM-Tg-bovg-T11615-Ab-2Anti-Bovine SLC7A11 monoclonal antibodyBovine
GM-Tg-equg-T11615-Ab-1/ GM-Tg-equg-T11615-Ab-2Anti-Equine SLC7A11 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T11615-Ab-1/ GM-Tg-hg-T11615-Ab-2; GM-Tg-rg-T11615-Ab-1/ GM-Tg-rg-T11615-Ab-2;
GM-Tg-mg-T11615-Ab-1/ GM-Tg-mg-T11615-Ab-2; GM-Tg-cynog-T11615-Ab-1/ GM-Tg-cynog-T11615-Ab-2;
GM-Tg-felg-T11615-Ab-1/ GM-Tg-felg-T11615-Ab-2; GM-Tg-cang-T11615-Ab-1/ GM-Tg-cang-T11615-Ab-2;
GM-Tg-bovg-T11615-Ab-1/ GM-Tg-bovg-T11615-Ab-2; GM-Tg-equg-T11615-Ab-1/ GM-Tg-equg-T11615-Ab-2
Products NameAnti-SLC7A11 monoclonal antibody
Formatmab
Target NameSLC7A11
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC7A11 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species XCT/ SLC7A11/ CCBR1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLV000645human SLC7A11 Lentivirus plasmid
    ORF Viral VectorvGMLP002698human SLC7A11 Lentivirus particle
    ORF Viral VectorpGMLP002698human SLC7A11 Lentivirus plasmid
    ORF Viral VectorvGMLV000645human SLC7A11 Lentivirus particle
    ORF Viral VectorpGMLPm004468mouse Slc7a11 Lentivirus plasmid
    ORF Viral VectorvGMLPm004468mouse Slc7a11 Lentivirus particle


    Target information

    Target IDGM-T11615
    Target NameSLC7A11
    Gene ID23657,26570,310392,696516,483821,101099374,524078,100063433
    Gene Symbol and Synonyms9930009M05Rik,CCBR1,SLC7A11,sut,xCT
    Uniprot AccessionQ9UPY5
    Uniprot Entry NameXCT_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000151012
    Target ClassificationN/A

    The target: SLC7A11, gene name: SLC7A11, also named as CCBR1, xCT. This gene encodes a member of a heteromeric, sodium-independent, anionic amino acid transport system that is highly specific for cysteine and glutamate. In this system, designated Xc(-), the anionic form of cysteine is transported in exchange for glutamate. This protein has been identified as the predominant mediator of Kaposi sarcoma-associated herpesvirus fusion and entry permissiveness into cells. Also, increased expression of this gene in primary gliomas (compared to normal brain tissue) was associated with increased glutamate secretion via the XCT channels, resulting in neuronal cell death. [provided by RefSeq, Sep 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.